The U.S. Food and Drug Administration (FDA) announced on February 28th that the prescribing information for cholesterol reducing drugs in the statin class will include warnings about the risk of increased blood sugar levels, HbA1c, and diagnoses of diabetes. Drugs in the statin class include: 1  Lipitor (atorvastatin) 2  Lescol (fluvastatin) 3  Mevacor (lovastatin)  Altoprev (lovastatin extended- 1 release) Livalo (pitavastatin)  Pravachol 1  (pravastatin) Crestor (rosuvastatin)  Zocor (simvastatin)